Somerset

Endo International PLC (NASDAQ: ENDP) is now trading at a favorable risk-reward profile and investors should be constructive on the stock, according to Citi. The Analyst Citi's Liav Abraham upgraded Endo International from Neutral to Buy with a price target lifted from $7 to $11. The...